Climatotherapy At The Dead Sea For Atopic Dermatitis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2009 by Hadassah Medical Organization.
Recruitment status was  Not yet recruiting
Information provided by:
Hadassah Medical Organization Identifier:
First received: July 6, 2009
Last updated: March 1, 2011
Last verified: July 2009

July 6, 2009
March 1, 2011
June 2009
November 2009   (final data collection date for primary outcome measure)
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
Climatotherapy At The Dead Sea For Atopic Dermatitis
Evaluation of the Efficacy of Dead Sea Climatotherapy on Atopic Dermatitis Patients.
The purpose of this study is to evaluate the improvement in severity of Atopic Dermatitis and quality of life after 4 weeks of treatment in the Dead Sea.

28 days treatment period, sun exposure and possibly Dead Sea baths after an exact given plan, discontinuation of all local Cortisone preparations, unlimited use of maintenance drags, doctor visit twice a week, continuous checks by the nurse.

Determination of the SCORAD index by the same doctor on arrival and departure. Before and after the treatment, the patient will answer written questionnaires regarding quality of life.

Observational Model: Case-Crossover
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Atopic Dermatitis patient.
Atopic Dermatitis
Not Provided
Before and after treatment
SCORAD of each patient before and after treatment.
Harari M, Shani J, Seidl V, Hristakieva E. Climatotherapy of atopic dermatitis at the Dead Sea: demographic evaluation and cost-effectiveness. Int J Dermatol. 2000 Jan;39(1):59-69.

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Not yet recruiting
December 2009
November 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Minimum age of 18 years old

Exclusion Criteria:

  • Skin type - I
  • Psoriasis patient in addition to Atopic Dermatitis
  • Pregnancy
  • Past malignancy
  • Less then 2 weeks of treatment
18 Years and older
Contact: Arik Tzukert, DMD +972-(0)2-6776095
Contact: Hadas Lemberg, PhD +972-(0)2-6777572
Hasassah Medical Organization IRB, Israel Ministry of Health
Hadassah Medical Organization
Not Provided
Study Chair: Arie Ingber, MD. Hadassa Medical Organization IRB
Hadassah Medical Organization
July 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP